Crossmark

Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer

Crossref DOI link: https://doi.org/10.1186/s13014-022-02025-2

Published Online: 2022-04-01

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ahmad Khalil, Dalia

Jazmati, Danny

Geismar, Dirk

Wulff, Jörg

Bäumer, Christian

Kramer, Paul Heinz

Steinmeier, Theresa

Schulze Schleitthoff, Stefanie

Plaude, Sandija

Bischoff, Martin

Tschirdewahn, Stephan

Hadaschik, Boris

Timmermann, Beate
Funding

Funding for this research was provided by:

Universitätsklinikum Essen
License Information

Text and Data Mining valid from 2022-04-01

Version of Record valid from 2022-04-01
More Information

Article History

Received: 1 December 2021

Accepted: 3 March 2022

First Online: 1 April 2022

Declarations

:

: This retrospective study was approved by the local ethical commission. All participants gave written informed consent.

: All authors gave consent for the publication.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below